Transform Translatable Autoimmune & Inflammatory Models for Accelerated Biomarker Discovery, Target Identification & PK/PD Prediction to Fast Track IND Success

This week is the last chance to save $367 on your attendance!

Explore registration options before time runs out.

Day
Hour
Minute
Second

Welcome to the Inaugural Autoimmune & Inflammatory Models Summit

Navigate Model Selection, Improve Translatability, Prepare for IND Submission

In 2025, investment in autoimmune and inflammatory disease R&D is surging, however, 90% of therapies still fail in the clinic due to poor model translatability. Success now hinges on tools that can better predict efficacy, de-risk pipelines, and align with evolving FDA expectations.

The Autoimmune & Inflammatory Models Summit is the only industry-driven meeting uniting leading pharma and biotech minds to share real world-case studies and cutting-edge strategies to advance translatable autoimmune and inflammatory models.

Explore how leaders like AbbVie, Pfizer, and Seismic Therapeutics are advancing complex models for target discovery, biomarker validation, and IND success, turning scientific insights into clinical wins.

Access the Full Event Guide: 

  • Meet the Speakers
  • View Full Session Details
  • Explore Registration Options
Autoimmune & Inflammatory Models Event Guide

Our World-Class Speaker Faculty Includes:

Today’s breakthrough therapies for autoimmune disease will not come from yesterday’s methodology. I am thrilled to attend a summit where drug discovery experts discuss the latest advances and case studies that exemplify cutting edge translational model systems.

Mark Panzenbeck, Senior Scientist, In Vivo Pharmacology, Bristol Myers Squibb, Expert Speaker

Access the Full Event Guide: 

  • Meet the Speakers
  • View Full Session Details
  • Explore Registration Options
Autoimmune & Inflammatory Models Event Guide